Tiếp theo

Tự chạy

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

10 Lượt xem • 07/08/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

UCLA oncologist Gottfried Konecny, MD, gives an overview of the PARP inhibitors olaparib, niraparib, and rucaparib, which have been approved for the treatment of ovarian cancers and how to proactively plan for and manage treatment-related toxicities. #UCLAMDChat

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy